Conferences
IGBA Global Biosimilars Week 2024
Global Biosimilars Week 2024
Advancing Access to Biosimilars
11-15 November 2024 | 5th Annual Edition | Online
ASBM/GaBI 2023 webinar on INTERCHANGEABILITY DESIGNATION FOR BIOSIMILARS
ASBM/GaBI 2023 webinar on Interchangeability Designation for Biosimilars
INTERCHANGEABILITY DESIGNATION FOR BIOSIMILARS
Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars
30 November 2023 | WATCH REPLAY
ASBM/GaBI 2023 webinar on MEDICARE DRUG PRICE NEGOTIATIONS
ASBM/GaBI 2023 Webinar on Inflation Reduction Act
MEDICARE DRUG PRICE NEGOTIATIONS:
impact on healthcare development and patient access to medicines
26 July 2023 | WATCH REPLAY
ASBM/GaBI 2022 biosimilar webinar on non-medical switching
ASBM/GaBI Biosimilar Webinar 2022
NON-MEDICAL SWITCHING OF BIOLOGICALS/BIOSIMILARS: CANADA, EUROPE AND THE US
Overview of Non-Medical Switching Practices in Different Regions and the Importance of Safeguarding the Physician–Patient Relationship
20 July 2022 | WATCH REPLAY
ASBM/GaBI 2022 biosimilar webinar on biosimilars uptake
ASBM/GaBI Biosimilar Webinar 2022
KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US
Measures taken for improving biosimilar uptake and the potential role of healthcare providers and patients
29 June 2022 | WATCH REPLAY
Pekka Kurki receives Van der Does Award
The 2023 Van der Does Award for rational and cost-effective drug treatment was presented to Dr Pekka Kurki at the Medicines for Europe Conference 2023, Amsterdam, The Netherlands.
DIA Europe 2023 – a brief report
The 35th edition of DIA Europe, the largest neutral forum for healthcare stakeholders in Europe, concluded on 24 March 2023 with resounding success. The three-day congress took place in Basel, Switzerland and attracted over 1,700 attendees from across the globe, making it a must-attend for the life sciences industry.
Microbiological control symposium: consensus on readiness of new methods emerges
A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.
European Pharmacopoeia prepares for the future through exchange with stakeholders
To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.
Extrapolation key issue at European biosimilars conference
The European Generic medicines Association (EGA) held its 13th EGA-European Biosimilars Group Conference in London on 23–24 April 2015.
